Poolbeg Pharma will trial its oral drug POLB 001 at six NHS hospitals to prevent cytokine release syndrome (CRS), a dangerous side-effect of cancer immunotherapy. The drug could improve patient safety and save healthcare systems millions by allowing treatment outside specialist centers.
New Medicaid work requirements, with stricter definitions of medical frailty, could cause many sick Americans to lose health coverage. Patients like DeAnna Brandon, a blood cancer survivor, worry they won't be able to meet the new proof requirements, despite being unable to work.
Elli Wust was 27 years old and pregnant with her first child when she found out her mum had a rare blood cancer. Now she has two children who never got to meet their cherished grandmother, who died at age 58.
A 24-year-old cancer patient in Foshan, China, sparked a viral relay of kindness after ordering companionship through a food delivery app on April 15. Little Li, battling rare blood cancer, asked a rider to sit by her bedside for two hours, highlighting her loneliness during treatment with her father working away to fund her care.
